Stay ahead of CF progression, treat the cause early
With ORKAMBI®▼ (lumacaftor/ivacaftor) you can now treat cystic fibrosis in patients aged 6 years and older who are homozygous for the F508del mutation in the CFTR gene1
What are you looking for?
1. ORKAMBI® Summary of Product Characteristics. February 2018. Vertex Pharmaceuticals (Europe) Limited.